Journey Medical (DERM) Other financing activities (2021 - 2026)
Journey Medical (DERM) posted Other financing activities of $148000.0 for Q1 2026, up 217.46% on a QoQ basis from -$126000.0 in Q4 2025, and up 49.49% year-over-year from $99000.0 in Q1 2025.
Journey Medical (DERM) Other financing activities (2021 - 2026) Analysis & Trends
Journey Medical's Other financing activities history runs 6 years deep, the most recent figure standing at $148000.0 for Q1 2026.
- Quarterly Other financing activities rose 49.49% year-over-year to $148000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $266000.0 (up 11.76% YoY) and the FY2025 annual result came in at $217000.0, up 4.83% from the prior year.
- Other financing activities was $148000.0 for Q1 2026 at Journey Medical, up from -$126000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $31.3 million in Q3 2022 and bottomed at -$126000.0 in Q4 2025.
- A 5-year average of $4.7 million and a median of $97500.0 in 2023 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 216.88% in 2025, while the deepest fall reached 380.0% in 2025.
- Journey Medical's Other financing activities stood at $31.3 million in 2022, then plunged by 99.69% to $96000.0 in 2023, then sank by 53.12% to $45000.0 in 2024, then slumped by 380.0% to -$126000.0 in 2025, then surged by 217.46% to $148000.0 in 2026.
- Business Quant data shows DERM's Other financing activities at $148000.0 in Q1 2026, -$126000.0 in Q4 2025, and $244000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148,000.00 |
| Mar 31, 2026 | 148,000.00 |
| Dec 31, 2025 | -126,000.00 |
| Dec 31, 2025 | -126,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | 96,000.00 |
| Dec 31, 2023 | 96,000.00 |
| Sep 30, 2023 | 21.35 Mn |
| Sep 30, 2023 | 21.35 Mn |